TXNIP is a mediator of insulin resistance in the liver, skeletal muscle, and adipose tissue and impaired pancreatic beta-cell insulin secretion [51,52,53] and TNFα decreases insulin receptor signaling in adipose tissue and skeletal muscle, particularly prior to the development of T2DM [54,55,56]. Here, INS is linked to Insulin resistance.